Elevated DHEA sulfate (DHEAS) indicates increased production of dehydroepiandrosterone sulfate, a hormone primarily secreted by the adrenal glands. This marker often reflects adrenal activity rather than direct disease, but persistently high levels may signal hormonal imbalance, adrenal tumors, or conditions like congenital adrenal hyperplasia.
DHEAS is the sulfated form of DHEA, the most abundant circulating steroid hormone in humans. It serves as a precursor to sex hormones, including testosterone and estrogen. Levels peak in early adulthood and decline steadily after age 30, making DHEAS a useful indicator of adrenal reserve and endocrine function.
Normal DHEAS ranges vary by lab, but typical reference values fall between 120-600 µg/dL for adults. Values above 600 µg/dL are considered elevated. A result of 850 µg/dL, for example, exceeds standard thresholds and warrants clinical follow-up.
The adrenal cortex produces DHEAS in response to adrenocorticotropic hormone (ACTH), which is released by the pituitary gland during stress. DHEAS circulates in the bloodstream and is converted into active androgens and estrogens in peripheral tissues. Its role in metabolism, immune function, and neuroprotection is still under study.
Unlike cortisol, which fluctuates daily, DHEAS maintains relatively stable levels throughout the day. This stability makes it a reliable biomarker for long-term adrenal activity. Because DHEAS is excreted slowly, it provides a longer-term view of adrenal output compared to acute cortisol testing.
A single elevated DHEAS level doesn't diagnose a condition. Instead, clinicians assess it alongside other tests such as 24-hour urinary free cortisol, ACTH stimulation, and imaging to rule out adrenal tumors or hyperplasia.
Adrenal hyperplasia due to enzyme deficiencies is a leading cause of high DHEAS. Congenital adrenal hyperplasia (CAH), particularly the non-classic form, affects about 1 in 100 people and presents with mild symptoms like irregular periods, acne, or hirsutism. In CAH, impaired cortisol synthesis leads to increased ACTH, which drives adrenal overproduction of DHEAS and other androgens.
Adrenal adenomas-benign tumors-are another frequent cause. These grow slowly and secrete excess hormones. A 2021 study in *The Journal of Clinical Endocrinology & Metabolism* found that 15% of patients with incidental adrenal masses had elevated DHEAS, though only 3% showed clinical signs of androgen excess.
Other contributors include polycystic ovary syndrome (PCOS), which can increase DHEAS in women despite normal adrenal function. Obesity and insulin resistance are linked to higher DHEAS levels, possibly due to altered steroid metabolism. Some medications, including certain anticonvulsants and corticosteroids, may also influence levels.
| Condition | Typical DHEAS Range | Associated Symptoms |
|---|---|---|
| Congenital adrenal hyperplasia (non-classic) | 600-1,200 µg/dL | Hirsutism, irregular menses, infertility |
| Adrenal adenoma | 700-1,500 µg/dL | Asymptomatic or mild virilization |
| Polycystic ovary syndrome (PCOS) | 400-800 µg/dL | Acne, weight gain, menstrual irregularity |
| Obesity-related metabolic changes | 300-700 µg/dL | Often asymptomatic |
Many assume high DHEA sulfate equals high testosterone or causes male-pattern hair growth in women. While DHEAS is a precursor to androgens, conversion rates vary widely. Not all individuals with elevated DHEAS develop symptoms. A 2019 review in *Endocrine Reviews* noted that only 30% of women with high DHEAS show measurable increases in free testosterone.
Another misconception is that DHEAS elevation always requires treatment. In many cases, especially in older adults or those with mild elevations, monitoring is sufficient. Over-treatment can lead to adrenal insufficiency or hormonal imbalances.
Some patients confuse DHEAS with DHEA supplements. Over-the-counter DHEA is not equivalent to DHEAS. Supplemental DHEA may raise serum DHEA, but not necessarily DHEAS. A 2020 trial in *Menopause* showed that 50 mg/day DHEA supplementation increased DHEA levels by 40%, but only raised DHEAS by 15% in postmenopausal women.
A 32-year-old woman presented with worsening acne and facial hair growth. Her labs showed DHEAS at 920 µg/dL, within the upper range of normal for her age group. Cortisol levels were normal, and ACTH was low. An abdominal CT scan revealed a 2.5 cm adrenal nodule. Biopsy confirmed a non-functioning adrenal adenoma. After surgical removal, DHEAS dropped to 580 µg/dL, and symptoms improved over six months.
This case illustrates that isolated high DHEA sulfate can stem from structural causes, even without overt hormonal syndromes. It also shows the importance of context-normal cortisol and ACTH ruled out primary adrenal hyperplasia.
If your DHEA sulfate is high, your doctor may order additional tests. A 24-hour urine collection for free cortisol and metanephrines helps exclude Cushing's syndrome or pheochromocytoma. An ACTH stimulation test evaluates adrenal responsiveness. Imaging, such as MRI or CT, identifies adrenal masses.
For women with signs of androgen excess-such as hirsutism, alopecia, or menstrual irregularity-evaluation for PCOS or CAH is essential. Men with elevated DHEA sulfate should be checked for adrenal tumors, especially if they have gynecomastia or decreased libido.
High DHEA sulfate is not a standalone diagnosis. It's a clue pointing toward underlying physiology. Persistent elevation requires structured assessment, not immediate intervention.
Always discuss abnormal lab values with a healthcare provider trained in endocrinology. Self-diagnosis based on DHEA sulfate levels risks unnecessary anxiety or inappropriate treatment.